Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial
Baxdrostat 2mg lowered systolic blood pressure by 15.7 mmHg (9.8 mmHg placebo-adjusted) from baseline, and was generally well tolerated with no unanticipated safety... Read more.
FS Launches DCS-W Series Optical Circuit Switches to Power Next-Gen AI and HPC Networks
NEW CASTLE, Del.–(BUSINESS WIRE)–#AI–FS, a trusted global provider of ICT products and solutions, announced the launch of its independently developed... Read more.
Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction
Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published... Read more.
$2 Billion Lower Amber Energy Bid Recommended by Special Master in CITGO Sale Process
PEMBROKE, Bermuda–(BUSINESS WIRE)–Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that... Read more.
Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development
– Dr. Aftab has served for over 25 years at Exelixis and has been instrumental in driving the company’s scientific innovation and development activities –... Read more.
Dustin Sedgwick joins Intapp as Chief Marketing Officer
PALO ALTO, Calif.–(BUSINESS WIRE)–Intapp (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets,... Read more.
San Francisco Bay University to Launch New Business Incubator, Innovate Bay
Designed to Advance Startups, Support Founders, and Strengthen Economic Opportunity Across the Bay Area FREMONT, Calif.–(BUSINESS WIRE)–On September... Read more.
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$SMLR—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing... Read more.
Nuveen Preferred Securities Closed-End Funds Announce Shareholder Approval of Proposed Merger
CHICAGO–(BUSINESS WIRE)–Common shareholders of Nuveen Preferred Securities & Income Opportunities Fund (NYSE: JPI) and preferred shareholders of... Read more.